Study: Ginger reduces nausea associated with chemotherapy
ROCHESTER, N.Y. People with cancer can reduce post-chemotherapy nausea by as much as 40% by using ginger supplements, along with standard antivomiting drugs, before undergoing treatment, according to scientists at the University of Rochester Medical Center.
About 70% of cancer patients who receive chemotherapy complain of nausea and vomiting.
“There are effective drugs to control vomiting, but the nausea is often worse because it lingers,” stated lead author Julie Ryan, assistant professor of dermatology and radiation oncology at Rochester’s James P. Wilmot Cancer Center. “Nausea is a major problem for people who undergo chemotherapy and it’s been a challenge for scientists and doctors to understand how to control it,” Ryan said.
The Phase II/III placebo-controlled, double-blind study included 644 cancer patients who would receive at least three chemotherapy treatments. They were divided into four arms that received placebos, 0.5 gram of ginger, 1 gram of ginger or 1.5 grams of ginger along with antiemetics (anti-vomiting drugs such as Zofran, Kytril, Novaban and Anzemet).
Patients took the ginger supplements three days prior to chemotherapy and three days following treatment. Patients reported nausea levels at various times of day during following their chemotherapy and those who took the lower doses had a 40% reduction.
Ginger is readily absorbed in the body and has long been considered a remedy for stomach aches. “By taking the ginger prior to chemotherapy treatment, the National Cancer Institute-funded study suggests its earlier absorption into the body may have anti-inflammatory properties,” Ryan said.
The research will be presented at the American Society of Clinical Oncology meeting in the Patient and Survivor Care Session on Saturday, May 30, in Orlando, Fla.
NACDS develops Marketplace Retail Scorecard
PALM BEACH, Fla. The National Association of Chain Drug Stores developed a results-driven resource for retailers attending the 2009 Marketplace conference, called the Marketplace Retail Scorecard. The scorecard focuses retailers on finding new vendors or products, identifying marketing and merchandising opportunities and resolving issues.
“Now, more than ever, retailers are ensuring that their business activities produce tangible results for their bottom lines,” stated Jim Whitman, NACDS SVP meetings and exhibits. “We urge retailers to utilize this new tool as a way to ensure that their business meetings are successful and yield results long after the NACDS Marketplace conference has taken place.”
The scorecard is divided into five “S.M.A.R.T.” deliverables — specific, measurable, attainable, relevant and time-bound — which will enable retailers to target their goals ahead of time, quantify them, conduct follow-up and plan accordingly for future business activities with suppliers, NACDS stated.
Juvenile Diabetes Research Foundation hosts annual event
WELLESLEY, Mass. The New England Chapter of the Juvenile Diabetes Research Foundation hopes to raise $1.5 million with a black-tie gala Saturday.
The chapter’s Massachusetts branch will have its 27th annual Hearts & Heroes Gala at the Boston Marriott Copley Place, paying tribute to Insulet Corp. president and CEO Duane DeSisto as honoree and giving the Nancy Jones Diabetes Champion Award to Massachusetts Sen. Edward Kennedy.
“In the fight against diabetes, we have one vision: to find a cure,” JDRF New England Chapter executive director Heidi Daniels said in a statement. “Duane DeSisto, Insulet Corp. and Sen. Kennedy are true champions in the hearts and minds of all of us with loved ones who have Type 1 diabetes.”